Dr. Reema Hammoud

AVP, clinical pharmacy
Dr. Reema Hammoud

Reema earned her doctorate of pharmacy from Ferris State University in 2006 and has nine years of experience as a pharmacist. She is board certified in pharmacotherapy and has experience working in a multitude of settings including community, hospital, and psychiatric.

Location: Southfield, MI
Areas of expertise: Drug abuse or misuse
Health and wellness
Managed care
Patient engagement
Media
View
Blog
July 28, 2022
Dr. Reema Hammoud
AVP, clinical pharmacy
The impact of sleep on employee safety and effectiveness

Did you know that approximately one third of Americans experience a sleep disorder at some point in their lives? It’s essential to address the root cause and determine the best course of action — for your health, safety and productivity. In thi…

July 28, 2022 by Dr. Reema Hammoud, AVP, clinical pharmacy
Blog
August 23, 2021
Dr. Reema Hammoud
AVP, clinical pharmacy
Clinicians: Look carefully at opioid tapering data and guidelines

While the COVID-19 pandemic forced its way into every aspect of our lives for the past 18 months, it is not the only major ongoing health crisis. The opioid epidemic is still a real threat to our population despite being somewhat overshadowed in the …

August 23, 2021 by Dr. Reema Hammoud, AVP, clinical pharmacy
Blog
May 24, 2021
Dr. Reema Hammoud
AVP, clinical pharmacy
COVID-19 long-haul claims and our clinical approach

With the advent of vaccines, we now have more hope in combating the COVID-19 pandemic, but there is still clinical data to digest and trends to keep a close eye on. One of them being long-haul cases. Most people infected by COVID-19 experience little…

May 24, 2021 by Dr. Reema Hammoud, AVP, clinical pharmacy
Blog
October 16, 2020
Dr. Reema Hammoud
AVP, clinical pharmacy
Psilocybin: From mysticism to healing

Imagine a drug that will take you on a mystical experience where you can ride a dragon or touch the stars, but imagine the same drug can suffocate you under quicksand or imprison you in a sea of volcanic ash. These experiences are not through the mec…

October 16, 2020 by Dr. Reema Hammoud, AVP, clinical pharmacy
Article
April 24, 2020
Dr. Reema Hammoud
AVP, clinical pharmacy
What employers need to know about employees microdosing cannabis at work

Dr. Hammoud contributed to this article

April 24, 2020 by Dr. Reema Hammoud, AVP, clinical pharmacy
Blog
August 23, 2019
Dr. Reema Hammoud
AVP, clinical pharmacy
Gabapentin and Lyrica: Safer alternatives for pain management?

The opioid epidemic in this country has left prescribers looking for pain treatment alternatives, and one emerging option has been anticonvulsants known as gabapentinoids (e.g. gabapentin and Lyrica®, also known as pregabalin). With a need for option…

August 23, 2019 by Dr. Reema Hammoud, AVP, clinical pharmacy
Blog
October 05, 2018
Dr. Reema Hammoud
AVP, clinical pharmacy
DEA and FDA clear Epidiolex: Where do we go from here?

On September 27, 2018, the Drug Enforcement Agency (DEA) made a remarkable move. The agency placed a cannabidiol (CBD) containing product, Epidiolex, into Schedule V (classified as having low potential for abuse) so that it could be manufactured in t…

October 05, 2018 by Dr. Reema Hammoud, AVP, clinical pharmacy
Sedgwick edge
December 07, 2017
Dr. Reema Hammoud
AVP, clinical pharmacy
Prescription drug (monitoring programs) + (the opioid epidemic)

For example, in Kentucky, Tennessee and New York, prescribers are legally required to check PDMP data when initially prescribing opioids. This has resulted in a decrease in the number of opioid prescriptions in each state of 8.5%, 7% and 9.5%, respec…

December 07, 2017 by Dr. Reema Hammoud, AVP, clinical pharmacy
Blog
October 27, 2017
Dr. Reema Hammoud
AVP, clinical pharmacy
Safety made simple: National Prescription Drug Take Back Day

Sedgwick routinely reminds clients and colleagues about the U.S. Drug Enforcement Administration’s (DEA’s) National Prescription Drug Take Back Days. The next Take Back Day will be this Saturday, October 28 from 10 a.m. – 2 p.m. In 2010, the DEA st…

October 27, 2017 by Dr. Reema Hammoud, AVP, clinical pharmacy
Blog
October 25, 2017
Dr. Reema Hammoud
AVP, clinical pharmacy
The pharmacist and the claim

Fostering awareness in the complex world of prescription drugs It is vital for a claims administrator to have pharmacists on staff because the current reality in workers’ compensation injury care is that prescription drug activity is a dangerous and…

October 25, 2017 by Dr. Reema Hammoud, AVP, clinical pharmacy
Blog
September 14, 2017
Dr. Reema Hammoud
AVP, clinical pharmacy
A portrait of opioid use disorder

A portrait of opioid use disorder Read part one of Rachel's story here. Rachel was once a vibrant gardener, grandmother and worker. Regrettably, following an injury, she became one of a growing number of those suffering from opioid use disorder (…

September 14, 2017 by Dr. Reema Hammoud, AVP, clinical pharmacy
Blog
August 31, 2017
Dr. Reema Hammoud
AVP, clinical pharmacy
Rachel’s story: A portrait of opioid use disorder

Rachel enjoyed gardening and canning vegetables. She enjoyed cooking, taking walks and spending time with her grandchildren. After she was injured at work, she was optimistic about making a speedy recovery. She was 53 years old and had always stayed …

August 31, 2017 by Dr. Reema Hammoud, AVP, clinical pharmacy
Blog
March 16, 2017
Dr. Reema Hammoud
AVP, clinical pharmacy
Slowly, steadily states striking against epidemic opioid issues

State governments are responding to the opioid epidemic. Recently, the New Jersey governor signed new legislation that limits prescribers’ capacity to provide first-time opioid prescriptions for more than five days. The New Jersey state senate passed…

March 16, 2017 by Dr. Reema Hammoud, AVP, clinical pharmacy
Video
January 17, 2016
Dr. Reema Hammoud
AVP, clinical pharmacy
Opioids: The domino effect webinar with Dr. Reema Hammoud and Dr. Paul Peak

January 17, 2016 by Dr. Reema Hammoud, AVP, clinical pharmacy
Blog
January 15, 2016
Dr. Reema Hammoud
AVP, clinical pharmacy
Misuse of antipsychotics in workers’ compensation patients

Antipsychotics are medications used for the treatment of acute and chronic psychosis and other psychotic conditions. Besides their defined indication by the Food and Drug Administration, antipsychotics are often used and misused for off-label condi…

January 15, 2016 by Dr. Reema Hammoud, AVP, clinical pharmacy
Authors
Back to top